---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-110952"
form_type: "8-K"
ticker: "IVVD"
cik: "0001832038"
company_name: "Invivyd, Inc."
filed_at: "2025-08-22T23:59:59+00:00"
generated_at: "2026-05-17T10:38:08.037975+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Invivyd closes $57.5M public offering; net proceeds ~$53.5M for pipeline development

## Summary
- Raised ~$57.5M gross ($53.5M net) via 89.2M shares at $0.52/sh and 21.3M pre-funded warrants at $0.5199.
- Underwriters' full option exercised; offering led by RA Capital Management and Janus Henderson.
- Proceeds to fund VYD2311 clinical program, RSV/measles R&D, and Long COVID studies (SPEAR Study Group).
- Dilution: total shares outstanding increases by ~110.6M (including pre-funded warrants exercisable).

## SEC filing metadata
- accession: 0000950170-25-110952
- form_type: 8-K
- ticker: IVVD
- cik: 0001832038
- company_name: Invivyd, Inc.
- filed_at: 2025-08-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832038/000095017025110952/0000950170-25-110952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832038/000095017025110952/ivvd-20250820.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-110952
- JSON: https://secwatch.observer/filing/0000950170-25-110952.json
- Plain text: https://secwatch.observer/filing/0000950170-25-110952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.